142 related articles for article (PubMed ID: 3493434)
1. Immunotherapy of cancer: the end of the beginning?
Durant JR
N Engl J Med; 1987 Apr; 316(15):939-41. PubMed ID: 3493434
[No Abstract] [Full Text] [Related]
2. Lymphokine-activated killer cells: a new approach to immunotherapy of cancer.
Rosenberg S
J Natl Cancer Inst; 1985 Oct; 75(4):595-603. PubMed ID: 3876465
[No Abstract] [Full Text] [Related]
3. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.
Rosenberg SA; Lotze MT; Muul LM; Chang AE; Avis FP; Leitman S; Linehan WM; Robertson CN; Lee RE; Rubin JT
N Engl J Med; 1987 Apr; 316(15):889-97. PubMed ID: 3493432
[TBL] [Abstract][Full Text] [Related]
4. [The activation of natural killer cells. A new approach to adoptive immunotherapy of tumors].
Schwarz R
Fortschr Med; 1988 Oct; 106(29):579-80. PubMed ID: 3266178
[No Abstract] [Full Text] [Related]
5. Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes.
Rosenberg SA; Lotze MT
Annu Rev Immunol; 1986; 4():681-709. PubMed ID: 3518753
[No Abstract] [Full Text] [Related]
6. Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer.
West WH; Tauer KW; Yannelli JR; Marshall GD; Orr DW; Thurman GB; Oldham RK
N Engl J Med; 1987 Apr; 316(15):898-905. PubMed ID: 3493433
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy of cancer by systemic administration of lymphoid cells plus interleukin-2.
Rosenberg SA
J Biol Response Mod; 1984 Oct; 3(5):501-11. PubMed ID: 6389777
[TBL] [Abstract][Full Text] [Related]
8. Adoptive immunotherapy of cancer using lymphokine activated killer cells and recombinant interleukin-2.
Rosenberg SA
Important Adv Oncol; 1986; ():55-91. PubMed ID: 3330541
[No Abstract] [Full Text] [Related]
9. Summary: potential of interleukin-2 for the therapy of cancer.
Herberman RB
J Biol Response Mod; 1984 Oct; 3(5):527-32. PubMed ID: 6389778
[No Abstract] [Full Text] [Related]
10. Natural killer cell-based immunotherapy in cancer: current insights and future prospects.
Sutlu T; Alici E
J Intern Med; 2009 Aug; 266(2):154-81. PubMed ID: 19614820
[TBL] [Abstract][Full Text] [Related]
11. [Interleukin 2].
Taguchi T; Kimoto Y
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1203-7. PubMed ID: 3495239
[TBL] [Abstract][Full Text] [Related]
12. [Use of interleukin 2-activated lymphocytes (LAK cells) in adoptive immunotherapy of neoplasms].
Robak T
Pol Tyg Lek; 1988 Nov; 43(47):1491-5. PubMed ID: 3266975
[No Abstract] [Full Text] [Related]
13. [Prospects for cancer immunotherapy using interleukin-1(IL-1) and interleukin-2(IL-2)].
Okuno K
Nihon Rinsho; 1983; 41(4):868-74. PubMed ID: 6350655
[No Abstract] [Full Text] [Related]
14. Human and mouse "LAK" cells expanded in long-term cultures: in vitro and in vivo studies.
Kedar E; Zeira E; Lebendiker Z; Weiss DW; Katan R; Shouval D
Prog Clin Biol Res; 1987; 244():59-75. PubMed ID: 3498959
[No Abstract] [Full Text] [Related]
15. Heterogeneity of cytotoxic lymphocytes potentially relevant for cellular immunotherapy of cancer: implications for designing clinical strategies.
Triebel F; Hercend T
Prog Clin Biol Res; 1987; 244():207-11. PubMed ID: 3498949
[No Abstract] [Full Text] [Related]
16. [Adoptive immunotherapy using cytapheresis].
Takago H; Sasakawa H; Kanizawa Y; Nojiri H; Ueno Y
Rinsho Ketsueki; 1986 Jul; 27(7):1242-6. PubMed ID: 3491233
[No Abstract] [Full Text] [Related]
17. Immunotherapy of cancer using interleukin 2: current status and future prospects.
Rosenberg SA
Immunol Today; 1988 Feb; 9(2):58-62. PubMed ID: 3076761
[No Abstract] [Full Text] [Related]
18. Immunotherapy of cancer with lymphokine-activated killer cells and recombinant interleukin-2.
Rosenberg SA; Mulé JJ
Surgery; 1985 Sep; 98(3):437-44. PubMed ID: 3898451
[TBL] [Abstract][Full Text] [Related]
19. The adoptive immunotherapy of cancer using the transfer of activated lymphoid cells and interleukin-2.
Rosenberg SA
Semin Oncol; 1986 Jun; 13(2):200-6. PubMed ID: 3520827
[No Abstract] [Full Text] [Related]
20. [Immunotherapy of tumors using interleukin-2 and lymphokine-activated killer cells].
Jost LM; Gmür J; Oelz O; Sauter C; Stahel RA
Schweiz Med Wochenschr; 1988 Feb; 119(5):137-43. PubMed ID: 3266369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]